Healthcare -
Biotechnology - NASDAQ - US
$ 23.46
-0.509 %
$ 3.38 B
Market Cap
-8.5
P/E
DNLI - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities DNLI - Denali Therapeutics Inc.
249 M
LAST VALUE
267.81%
2 YEAR CAGR
23.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR